By contrast, we observed no differences in expression of BCL2 between wild-type and mutant GC B cells (Fig 4A and 4B) The same was true for BCL6 (Fig 4C and 4D) and BAFF-R that is an FBXO11 target in lymphoma (Fig 4E and 4F). Here, BCL2 is linked to lymphoma.